This is a solicitation for pharmaceutical products, specifically diltiazem equivalent capsules, to be distributed through the VA and DOD pharmaceutical prime vendor programs. Offerors must submit prices for the base year and four option years, including a 0. 5% cost recovery fee. Packaging requirements include safety caps and specific bottle volumes. Bar coding is mandatory. Manufacturers must have FDA CGMP acceptable status. Offerors must provide unique NDC numbers and adhere to trade agreement regulations. Small business subcontracting plans are required for contracts over $900,000. Proposals are due by August 7, 2026, and should be submitted electronically. The contract will be awarded to the lowest price technically acceptable offer.
The implementation period for delivery begins on the contract effective date and ends at the start of the ordering period, with a maximum of 60 days. The ordering period for the base year is one year, with four one-year pre-priced option ordering periods. The contractor shall ensure sufficient inventory is available for distribution by the expiration of the contract implementation period.
The bid notice states that contractors will be receiving payments from the PPV programs instead of directly from the government. Invoices are to be submitted in accordance with the business-to-business agreements reached with the PPV programs, and no invoices will be provided from the contractor to the government ordering facilities.
The bid notice states that the contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.
The bid notice states that the contract will be awarded to the responsible offeror that submits an offer meeting the solicitation requirements, and is the lowest price technically acceptable offer.
To be considered for award, offerors must submit a price for the base year and all four one-year options for all line items. Offerors must list an 11-digit NDC number for each offered drug that is unique to the offeror's company. If the offeror is a distributor, the NDC number must be unique to the distributor. Offerors must also meet packaging requirements and have FDA CGMP acceptable status for manufacturing facilities.
Failure to provide awarded product meeting all solicitation contract requirements by the ordering period start date may result in contract termination in accordance with FAR ****(m), contract terms and conditions—commercial products and commercial services, termination for cause. Willful failure or refusal to furnish the required reports, or falsification thereof, shall constitute sufficient cause for terminating the contract.
The bid notice states that protests, as defined in section **** of the Federal Acquisition Regulation, that are filed directly with an agency, and copies of any protests that are filed with the Government Accountability Office (GAO), shall be served on the contracting officer. The copy of any protest shall be received in the office designated above within one day of filing a protest with the GAO.